Ticagrelor and omeprazole: A desirable combination in post MI patients?

Ticagrelor and omeprazole: A desirable combination in post MI patients?

Bibliographic Details
Main Author:	Dimitrios Alexopoulos
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Hellenic Journal of Cardiology
Subjects:	Ticagrelor omeprazole myocardial infarction proton pump inhibitors
Online Access:	http://www.sciencedirect.com/science/article/pii/S1109966620302438

Similar Items

Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI
by: Fucheng Zhang, et al.
Published: (2020-09-01)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
by: Fatemeh Famouri, et al.
Published: (2020-01-01)

Effects of Omeprazole on Iron Absorption: Preliminary Study
by: Mahmut Yaşar Çeliker, et al.
Published: (2013-09-01)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01)

Alendronate and omeprazole in combination reduce angiogenic and growth signals from osteoblasts
by: Tormod B. Krüger, et al.
Published: (2021-06-01)

Omeprazole prescriptions for older adults in health care units in Curitiba, Brazil: an analysis based on Beers Criteria
by: Juliana Sambugaro, et al.
Published: (2021-12-01)

Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
by: Keisuke Mine, et al.
Published: (2022-08-01)

Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction
by: Lucas C. Pinheiro, et al.
Published: (2016-10-01)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01)

Concomitant acute interstitial nephritis and autoimmune hemolytic anemia induced by omeprazole
by: Neetu Sharma, et al.
Published: (2020-02-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
by: A.V. Savustyanenko
Published: (2014-11-01)

Effect of systemic administration of omeprazole on osseointegration around titanium dental implants: A histomorphometric study in dogs
by: Negar Kanounisabet, et al.
Published: (2021-01-01)

Synergistic Effects of Omeprazole and Metformin on Glycemic Control in Type 2 Diabetic Patients. A Randomized Clinical Study
by: Fizzah Ali, et al.
Published: (2017-04-01)

Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
by: Sara Seife Hassen, et al.
Published: (2020-12-01)

Ticagrelor regulates the differentiation of MDSCs after acute myocardial infarction to reduce cardiac injury
by: Zijian Huang, et al.
Published: (2024-03-01)

Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants
by: Samet Tekin, et al.
Published: (2021-04-01)

Successful Caesarean Section on Ticagrelor Treatment One Day after Primary Percutaneous Coronary Intervention
by: Nebojsa Antonijevic, et al.
Published: (2023-08-01)

Synergistic Effects of Omeprazole and Metformin on Glycemic Control in Type 2 Diabetic Patients. A Randomized Clinical Study
by: Fizzah Ali, et al.
Published: (2017-04-01)

Synergistic Effects of Omeprazole and Metformin on Glycemic Control in Type 2 Diabetic Patients. A Randomized Clinical Study
by: Fizzah Ali, et al.
Published: (2017-04-01)

Occupational contact allergy to omeprazole and ranitidine
by: Inmaculada Herrera-Mozo, et al.
Published: (2017-06-01)

Omeprazole Minimally Alters the Fecal Microbial Community in Six Cats: A Pilot Study
by: Sarah M. Schmid, et al.
Published: (2018-04-01)

AN LC- MS/MS METHOD FOR THE DETERMINATION OF OMEPRAZOLE ON PROTON PUMP INHIBITOR IN HUMAN PLASMA
by: T. Sudha, et al.
Published: (2016-04-01)

Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report
by: Theodore W. Perry
Published: (2021-07-01)

Proteção da recuperação funcional do miocárdio pelo omeprazol após isquemia-reperfusão em corações isolados de ratos Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts
by: Otoni Moreira Gomes, et al.
Published: (2010-09-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
by: S.M. Tkach
Published: (2014-02-01)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
by: Piotr Adamski, et al.
Published: (2022-02-01)

Acute Hypersensitivity Reaction Related to use of Pantoprazole Lacking Cross-Reactivity with Omeprazole
by: Hemangini Rajanikant Acharya, et al.
Published: (2018-06-01)

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
by: Marc P. Bonaca, et al.
Published: (2018-11-01)

Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report
by: Daniel Cesarini, et al.
Published: (2023-06-01)

Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder
by: Harini Sri Rethinavel, et al.
Published: (2022-06-01)

Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?
by: O. V. Averkov, et al.
Published: (2018-09-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
by: Salman Nikfarjam, et al.
Published: (2023-01-01)

A real-world retrospective study of omeprazole–domperidone combination in managing acid peptic disease with PRoton-pump Inhibitors in patients with type 2 DiabEtes mellitus (PRIDE-2)
by: Bharat Saboo, et al.
Published: (2023-02-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Karla N. Samman, et al.
Published: (2021-06-01)

A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole
by: Badriul Hegar, et al.
Published: (2013-07-01)

Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia
by: Yousif A. Alosaily, et al.
Published: (2023-09-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01)

Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
by: Tahmina Nasrin Poly, et al.
Published: (2022-10-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)